Anthracycline formulations
US10328093B2 · kind B2 · utility
0Cited by
4References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2017 |
| Grant date | Jun 25, 2019 |
| Priority date | — |
| Expiry date | May 9, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to reconstituted formulations comprising an anthracycline compound, ethanol, and water. The invention also relates to injectable compositions comprising the reconstituted formulation and Lactated Ringer's solution. Additionally, the invention relates to methods of using the formulations and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.